Lv11
48 积分 2024-04-27 加入
OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours
26天前
已完结
Bispecific killer cell engager-secreting CAR-T cells redirect natural killer specificity to enhance antitumour responses
1个月前
已完结
Bispecific killer cell engager-secreting CAR-T cells redirect natural killer specificity to enhance antitumour responses
2个月前
已完结
Rewiring cancer metabolism: oncogenic signaling pathways and targeted therapeutics
3个月前
已完结
Stem cell-mediated recovery in stroke: partnering with the immune system
4个月前
已完结
In vivo AAV–SB-CRISPR screens of tumor-infiltrating primary NK cells identify genetic checkpoints of CAR-NK therapy
5个月前
已完结
[Isolation, amplification and identification of human natural CD4⁺CD25⁺ regulatory T cells in vitro]
6个月前
已完结
New Treg cell-based therapies of autoimmune diseases: towards antigen-specific immune suppression
6个月前
已完结
Treg cells in autoimmunity: from identification to Treg-based therapies
6个月前
已完结
Natural killer cells: a new promising source for developing chimeric antigen receptor anti-cancer cells in hematological malignancies
8个月前
已完结
皖公网安备34019202002308
